Catalio Capital Management, LP
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 1958125
NEW YORK, NY
Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,575,158
+$2,195,027 QoQ
Shares Held
1,215,698
+16.5% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
4.99%
of 13F equity value
Holder Rank
#27
of 238 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Catalio Capital Management, LP holds $385,997,200 across 31 Biotechnology names. SNDX ranks #3 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVLN |
Avalyn Pharma Inc.
|
1,675,830 | $55,168,323 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
455,041 | $33,891,453 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
This page
|
1,215,698 | $26,575,158 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
562,672 | $26,468,090 | |
| 5 | PBLS |
Parabilis Medicines, Inc.
|
824,043 | $22,554,056 | |
| 6 | INCY |
Incyte Corp
|
191,627 | $21,722,836 | |
| 7 | SEPN |
Septerna, Inc.
|
536,152 | $17,955,730 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
648,722 | $17,502,519 |
All Filings in SNDX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,575,158 | 1,215,698 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,380,131 | 1,043,670 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,144,915 | 1,196,807 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,842,421 | 1,614,717 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,708,754 | 2,104,512 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $21,298,516 | 1,733,701 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||